DSIJ Mindshare

From Rs 40 to Rs 500: This multibagger Smallcap pharma stock recorded over 1000 per cent returns in just 3 years! Know its story here

The capsule manufacturing capacity is around 18 BCPA (Billion capsules per annum), which is likely to see a significant rise to 22 BCPA via capital expansion in this fiscal year.

Rohit Kale 0 1021 Article rating: 4.2

This smallcap company, belonging to the pharma domain, has exhibited strong growth phase along with improvement in financial numbers.

Stock below Rs 300: Don’t miss out the action in this SME stock having huge potential in industrial applications!

Being a prominent player in the sector, the company has consistently shown rising sales and net profitability.

Rohit Kale 0 2445 Article rating: 4.3

If there is one segment in the domestic market which is buzzing and gushing, it has to be the IPOs of small and medium enterprises (SME). The increasing popularity of SME stocks has certainly gained the limelight among the retail and HNI groups.

Here's a list of top 10 gainers in the second week of April! Do you own any?

Midcap and Smallcap stocks outperformed the value stocks and good quality stocks are up anywhere between 12 to 35 per cent on MTD basis.

Rohit Kale 0 1079 Article rating: 4.0

Considering such bullish sentiment, we have listed out the top 10 gainers from Group A of BSE listed stock for the second week of April, which should be in your watchlist for upcoming trading sessions!

RSS
135678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR